An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma
T. E. Witzig, J. M. Vose, P. L. Zinzani, C. B. Reeder, R. Buckstein, J. A. Polikoff, R. Bouabdallah, C. Haioun, H. Tilly, P. Guo, D. Pietronigro, A. L. Ervin-Haynes, M. S. Czuczman
Dive into the research topics of 'An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma'. Together they form a unique fingerprint.